"Drug Approval" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.
| Descriptor ID |
D017277
|
| MeSH Number(s) |
E05.337.300 I01.880.604.605.250.250
|
| Concept/Terms |
Drug Approval- Drug Approval
- Approval, Drug
- Approvals, Drug
- Drug Approvals
- Food and Drug Administration Drug Approval
Drug Approval Process- Drug Approval Process
- Approval Process, Drug
- Approval Processes, Drug
- Drug Approval Processes
- Process, Drug Approval
- Processes, Drug Approval
New Drug Approval- New Drug Approval
- Approval, New Drug
- Approvals, New Drug
- Drug Approval, New
- Drug Approvals, New
- New Drug Approvals
|
Below are MeSH descriptors whose meaning is more general than "Drug Approval".
Below are MeSH descriptors whose meaning is more specific than "Drug Approval".
This graph shows the total number of publications written about "Drug Approval" by people in this website by year, and whether "Drug Approval" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 4 | 6 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 3 | 5 |
| 2017 | 50 | 40 | 90 |
| 2018 | 27 | 25 | 52 |
| 2019 | 13 | 21 | 34 |
| 2020 | 30 | 29 | 59 |
| 2021 | 7 | 23 | 30 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Approval" by people in Profiles.
-
Understanding Drug Development: A Primer on the Food and Drug Administration. J Pediatric Infect Dis Soc. 2021 Nov 11; 10(10):977-981.
-
Ronapreve for prophylaxis and treatment of covid-19. BMJ. 2021 09 02; 374:n2136.
-
FDA's commitment to transparency. Am J Health Syst Pharm. 2021 08 30; 78(17):1550-1551.
-
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic. Pharmaceut Med. 2021 07; 35(4):203-213.
-
Vaccine design and delivery approaches for COVID-19. Int Immunopharmacol. 2021 Nov; 100:108086.
-
An urgent call to raise the bar in oncology. Br J Cancer. 2021 11; 125(11):1477-1485.
-
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
-
COVID-19 vaccines approved in the European Union: current evidence and perspectives. Expert Rev Vaccines. 2021 10; 20(10):1195-1199.
-
Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data. Expert Opin Drug Saf. 2021 Dec; 20(12):1559-1564.
-
Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent. Exp Clin Transplant. 2021 08; 19(8):753-762.